ShangPharma said it saw revenue climb on higher customer spending in the fourth quarter, but that margins slid due to currency effects and higher share-based compensation.
Contract services firm Almac aims to expand its trial patient management and compliance offering though a new partnership with ePRO specialist Exco InTouch.
Next month the United Nations Conference on Trade and Development (UNCTAD) will organise a meeting to discuss ways of encouraging the production of pharmaceutical in Africa.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Cytel and Laureate Biopharmaceutical.
The EMA and the US FDA will conduct parallel assessment of QbD development and manufacturing data for new drug submissions under a new pilot scheme announced this week.
Shanghai-based CRO, ChemPartner, a subsidiary of Chinese biotech outsourcing company, ShangPharma, has signed a research services agreement with China-based oncology specialists, Shenogen Pharma, to develop therapeutic antibodies for use in the treatment...
Almac Clinical Services has added to installed two new automated wallet presses at its facilities in Craigavon, Northern Ireland and Pennsylvania in the US.
SAFC, the custom manufacturing wing of global healthcare giant Sigma Aldritch, has announced the launch of raw materials and custom services specifically developed for point-of-care (POC) diagnostics manufacture.
US contractor Multi Packaging Solutions plans to expand its label and carton manufacturing facility in Holland, Michigan to cater for growing demand from the pharmaceutical industry.
World Street Fundamentals (WSF), the financial research specialist, has released two industry reports highlighting the mixed fortunes of biotech firms Biodel and MannKind, but claims a “brighter decade” lies ahead for the biotech sector.
Don’t think of the global regulatory information clampdown as a burden. It’s an opportunity to put your house in order, says Adam Sherlock, MD of ISI Europe.
Cytovance Biologics, the US-based biopharmaceutical contract manufacturer (CMO), has secured a growth equity investment from Connecticut, US-based private investors, Great Point Partners.
Informed Medical Communications (IMC) a healthcare communications and training provider, has merged with training program designer and developer, IC Axon.
Leading players in the Japanese contract research sector have predicted ongoing disruption to trials in the aftermath of the massive earthquake and tsunami that struck the country last week.
GlaxoSmithKline (GSK) has partnered with Nigeria's National Agency for Food and Drug Administration Control (NAFDAC) to provide a patient SMS verification service for its antibiotic, Ampiclox..
Johnson & Johnson, the multinational healthcare giant, has announced it has finalised the terms of a consent decree with the FDA over its stricken McNeil PPC manufacturing plants.
Researchers have uncovered a link between exposure to sunlight and the body's ability to break down medicines that could have big implications for formulators.
US drug giant Pfizer may sell its generics, consumer health and Capsugel units in an effort to slim down and refocus on its core pharmaceutical business according to a number of reports.
A customer decision to halt development of an antibiotic and end a manufacturing contract early helped Patheon to an improved set results for the first quarter of fiscal 2011.
Applying a business model based on marketing theory to clinical trials can give a consistent framework for planning and managing patient recruitment, say academics.
SOCMA and the EFCG want the US FDA to make inspection of overseas API manufacturing sites mandatory, with the facilities paying for the costs themselves.
Nimbus Discovery has signed up Microsoft CEO Bill Gates and Richard Friesner, co-founder of chemical simulation software developer Schrodinger, as investors.
CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.
The Japanese drug sector seems to have survived the earthquake and tsunami that struck the country largely unscathed, with early reports suggesting that most manufacturing sites have escaped damage.
in-PharmaTechnologist presents its latest round-up of movements in the pharma sector including appointments at Sanofi, GSK, Eli Lilly and Watson Pharmaceuticals.
Supply chain services firm Tracelink says that half of Catalent Pharma Solutions’ US manufacturing sites have been added to its network under the strategic partnership signed last summer.
West Pharmaceutical Services will invest $29m to expand its syringe plungers and intravenous (IV) system components facility in Kinston, North Carolina, in the US.
Wuxi PharmaTech finished the fourth quarter and the full year 2010 on a high driven by growth across all business units and the payoff from former suitor Charles River Laboratories (CRL).
Outsourcing-pharma.com presents a round up of the latest partnerships in the clinical research services sector, with news from Covance, ISB, Emergo, Data Pharma and Integra and RxTrials.
Regional production hubs created by technology transfer can improve public health and drive economic development in low- to mid-income countries, says Eli Lilly
RainDance Technologies, manufacturer of microdroplet-based analysis equipment, has announced it will collaborate with Roche-owned gene sequencing specialists, 454 Life Sciences, to develop a series of next generation sequencing solutions for drug discovery..
Sanofi Aventis has had a busy few days with media speculation about potential job cuts following just 24 hours after the firm extended its takeover offer for Genzyme.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Gentium, Endo Pharmaceuticals and American Peptide Company.